Diagnostic Radiopharmaceuticals & Contrast Media Market: Global Market Size, Forecast, Insights, and Competitive

The global diagnostic radiopharmaceuticals & contrast media market is expected to grow at a CAGR of around 3.1% during 2021-2027. This report on global diagnostic radiopharmaceuticals & contrast media market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global diagnostic radiopharmaceuticals & contrast media market by segmenting the market based on type, procedure, application, and region. Also, detailed profiles of companies operating in the diagnostic radiopharmaceuticals & contrast media market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

• Technological Advancements in the Minimally Invasive Therapeutic Procedures
• Rising Cases of Cancer

Market Challenges

• Stringent Regulatory Framework
• Shorter Half-life of Radiopharmaceuticals

Historical & Forecast Period

Base Year: 2020
Historical Period: 2016-2020
Forecast Period: 2021-2027

Radiopharmaceuticals Type Segmentation

• SPECT
  o Tc-99
  o Tl-201
  o Ga-67
  o I-123
  o Other SPECTs
• PET
  o F-18
  o Rb-82
  o Other PETs

Radiopharmaceuticals Application Segmentation

• Diagnostics
  o Cardiology
  o Oncology
  o Neurology
  o Others
• Therapeutics
  o Thyroid
  o Lymphoma
  o Endocrine Tumors
  o Others

Contrast Media Type Segmentation

• Iodinated Contrast Media
• Gadolinium-based Contrast Media
• Microbubble Contrast Media
• Barium-based Contrast Media

Contrast Media Procedure Segmentation

• X-ray/Computed Tomography (CT)
• Magnetic Resonance Imaging (MRI)
• Ultrasound

Contrast Media Application Segmentation

• Cardiovascular Disease
• Oncology
• Gastrointestinal Disorders
• Neurological Disorders
• Other Indications

Market by Region

• Europe
  o Germany
  o United Kingdom
  o France
  o Italy
  o Spain
  o Russia
  o Netherlands
  o Rest of Europe
• North America
  o United States
  o Canada
• Asia Pacific
  o China
  o Japan
  o India
  o South Korea
  o Australia
  o Indonesia
  o Rest of Asia Pacific
• Latin America
  o Mexico
  o Brazil
  o Argentina
  o Rest of Latin America
• Middle East & Africa
  o Saudi Arabia
  o Turkey
  o Iran
  o United Arab Emirates
  o Rest of Middle East & Africa

1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Diagnostic Radiopharmaceuticals & Contrast Media Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
5. Global Radiopharmaceuticals Market by Type
5.1. Introduction
5.2. SPECT
5.2.1. Tc-99
5.2.2. Tl-201
5.2.3. Ga-67
5.2.4. I-123
5.2.5. Other SPECTs
5.3. PET
5.3.1. F-18
5.3.2. Rb-82
5.3.3. Other PETs
6. Global Radiopharmaceuticals Market by Application
6.1 Introduction
6.2 Diagnostics
6.2.1 Cardiology
6.2.2 Oncology
6.2.3 Neurology
6.2.4 Others
6.3 Therapeutics
6.3.1 Thyroid
6.3.2 Lymphoma
6.3.3 Endocrine Tumors
6.3.4 Others
7. Global Contrast Media Market by Type
7.1 Introduction
7.2 Iodinated Contrast Media
7.3 Gadolinium-based Contrast Media
7.4 Microbubble Contrast Media
7.5 Barium-based Contrast Media
8. Global Contrast Media Market by Procedure
8.1 Introduction
8.2 X-ray/Computed Tomography (CT)
8.3 Magnetic Resonance Imaging (MRI)
8.3 Ultrasound
9. Global Contrast Media Market by Application
9.1 Introduction
9.2 Cardiovascular Disease
9.3 Oncology
9.4 Gastrointestinal Disorders
9.5 Neurological Disorders
9.6 Other Indications
10. Global Diagnostic Radiopharmaceuticals & Contrast Media Market by Region
10.1 Introduction
10.2 Europe
10.2.1 Germany
10.2.2 United Kingdom
10.2.3 France
10.2.4 Italy
10.2.5 Spain
10.2.6 Russia
10.2.7 Netherlands
10.2.8 Rest of the Europe
10.3 North America
10.3.1 United States
10.3.2 Canada
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Australia
10.4.6 Indonesia
10.4.7 Rest of the Asia Pacific
10.5 Latin America
10.5.1 Mexico
10.5.2 Brazil
10.5.3 Argentina
10.5.4 Rest of Latin America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 Turkey
10.6.3 Iran
10.6.4 United Arab Emirates
10.6.5 Rest of Middle East & Africa
11. SWOT Analysis
12. Porter’s Five Forces
13. Market Value Chain Analysis
14. Competitive Landscape
14.1 Competitive Scenario
14.2 Company Profiles
14.2.1 Bayer AG
14.2.2 Bracco Imaging SpA
14.2.3 Cardinal Health Inc.
14.2.4 Curium
14.2.5 GE Healthcare
14.2.6 Guerbet Group
14.2.7 Lantheus Holdings Inc.
14.2.8 Nordion Inc.
14.2.9 NTP Radioisotopes SOC Ltd
14.2.10 Siemens Healthineers

List of Figures

Figure 1: Global Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2016-2020
Figure 2: Global Radiopharmaceuticals Market by Type, 2020
Figure 3: Global Radiopharmaceuticals Market by Application, 2020
Figure 4: Global Contrast Media Market by Type, 2020
Figure 5: Global Contrast Media Market by Procedure, 2020
Figure 6: Global Contrast Media Market by Application, 2020
Figure 7: Global Diagnostic Radiopharmaceuticals & Contrast Media Market by Region, 2020
Figure 8: Global Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2021-2027
Figure 9: Global Radiopharmaceuticals Market by Type (in %), 2020 & 2027
Figure 10: Global SPECT Radiopharmaceuticals Market (in US$ Million), 2016-2020
Figure 11: Global SPECT Radiopharmaceuticals Market (in US$ Million), 2021-2027
Figure 12: Global TC-99 Market (in US$ Million), 2016-2027
Figure 13: Global TI-201 Market (in US$ Million), 2016-2027
Figure 14: Global Ga-67 Market (in US$ Million), 2016-2027
Figure 15: Global I-123 Market (in US$ Million), 2016-2027
Figure 16: Global Other SPECT Market (in US$ Million), 2016-2027
Figure 17: Global PET Radiopharmaceuticals Market (in US$ Million), 2016-2020
Figure 18: Global PET Radiopharmaceuticals Market (in US$ Million), 2021-2027
Figure 19: Global F-18 Market (in US$ Million), 2016-2027
Figure 20: Global Rb-82 Market (in US$ Million), 2016-2027
Figure 21: Global Other PETs Market (in US$ Million), 2016-2027
Figure 22: Global Radiopharmaceuticals Market by Application (in %), 2020 & 2027
Figure 23: Global Radiopharmaceuticals Diagnostics Market (in US$ Million), 2016-2020
Figure 24: Global Radiopharmaceuticals Diagnostics Market (in US$ Million), 2021-2027
Figure 25: Global Cardiology Diagnostics Market (in US$ Million), 2016-2027
Figure 26: Global Oncology Diagnostics Market (in US$ Million), 2016-2027
Figure 27: Global Neurology Diagnostics Market (in US$ Million), 2016-2027
Figure 28: Global Other Diagnostics Market (in US$ Million), 2016-2027
Figure 29: Global Radiopharmaceuticals Therapeutics Market (in US$ Million), 2016-2020
Figure 30: Global Radiopharmaceuticals Therapeutics Market (in US$ Million), 2021-2027
Figure 31: Global Thyroid Therapeutics Market (in US$ Million), 2016-2027
Figure 32: Global Lymphoma Therapeutics Market (in US$ Million), 2016-2027
Figure 33: Global Endocrine Tumors Therapeutics Market (in US$ Million), 2016-2027
Figure 34: Global Other Therapeutics Market (in US$ Million), 2016-2027
Figure 35: Global Contrast Media Market by Type (in %), 2020 & 2027
Figure 36: Global Iodinated Contrast Media Market (in US$ Million), 2016-2020
Figure 37: Global Iodinated Contrast Media Market (in US$ Million), 2021-2027
Figure 38: Global Gadolinium-based Contrast Media Market (in US$ Million), 2016-2020
Figure 39: Global Gadolinium-based Contrast Media Market (in US$ Million), 2021-2027
Figure 40: Global Microbubble Contrast Media Market (in US$ Million), 2016-2020
Figure 41: Global Microbubble Contrast Media Market (in US$ Million), 2021-2027
Figure 42: Global Barium-based Contrast Media Market (in US$ Million), 2016-2020
Figure 43: Global Barium-based Contrast Media Market (in US$ Million), 2021-2027
Figure 44: Global Contrast Media Market by Procedure (in %), 2020 & 2027
Figure 45: Global Contrast Media for X-ray/Computed Tomography (CT) Market (in US$ Million), 2016-2020
Figure 46: Global Contrast Media for X-ray/Computed Tomography (CT) Market (in US$ Million), 2021-2027
Figure 47: Global Contrast Media for Magnetic Resonance Imaging (MRI) Market (in US$ Million), 2016-2020
Figure 48: Global Contrast Media for Magnetic Resonance Imaging (MRI) Market (in US$ Million), 2021-2027
Figure 49: Global Contrast Media for Ultrasound Market (in US$ Million), 2016-2020
Figure 50: Global Contrast Media for Ultrasound Market (in US$ Million), 2021-2027
Figure 51: Global Contrast Media Market by Application (in %), 2020 & 2027
Figure 52: Global Contrast Media for Cardiovascular Disease Market (in US$ Million), 2016-2020
Figure 53: Global Contrast Media for Cardiovascular Disease Market (in US$ Million), 2021-2027
Figure 54: Global Contrast Media for Oncology Market (in US$ Million), 2016-2020
Figure 55: Global Contrast Media for Oncology Market (in US$ Million), 2021-2027
Figure 56: Global Contrast Media for Gastrointestinal Disorders Market (in US$ Million), 2016-2020
Figure 57: Global Contrast Media for Gastrointestinal Disorders Market (in US$ Million), 2021-2027
Figure 58: Global Contrast Media for Neurological Disorders Market (in US$ Million), 2016-2020
Figure 59: Global Contrast Media for Neurological Disorders Market (in US$ Million), 2021-2027
Figure 60: Global Contrast Media for Other Diseases Market (in US$ Million), 2016-2020
Figure 61: Global Contrast Media for Other Diseases Market (in US$ Million), 2021-2027
Figure 62: Global Diagnostic Radiopharmaceuticals & Contrast Media Market by Region (in %), 2020 & 2027
Figure 63: Europe Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2016-2020
Figure 64: Europe Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2021-2027
Figure 65: Europe Diagnostic Radiopharmaceuticals & Contrast Media Market by Country (in %), 2020 & 2027
Figure 66: Germany Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2016-2027
Figure 67: United Kingdom Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2016-2027
Figure 68: France Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2016-2027
Figure 69: Italy Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2016-2027
Figure 70: Spain Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2016-2027
Figure 71: Russia Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2016-2027
Figure 72: Netherlands Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2016-2027
Figure 73: North America Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2016-2020
Figure 74: North America Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2021-2027
Figure 75: North America Diagnostic Radiopharmaceuticals & Contrast Media Market by Country (in %), 2020 & 2027
Figure 76: United States Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2016-2027
Figure 77: Canada Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2016-2027
Figure 78: Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2016-2020
Figure 79: Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2021-2027
Figure 80: Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Market by Country (in %), 2020 & 2027
Figure 81: China Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2016-2027
Figure 82: Japan Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2016-2027
Figure 83: India Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2016-2027
Figure 84: South Korea Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2016-2027
Figure 85: Australia Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2016-2027
Figure 86: Indonesia Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2016-2027
Figure 87: Latin America Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2016-2020
Figure 88: Latin America Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2021-2027
Figure 89: Latin America Diagnostic Radiopharmaceuticals & Contrast Media Market by Country (in %), 2020 & 2027
Figure 90: Mexico Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2016-2027
Figure 91: Brazil Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2016-2027
Figure 92: Argentina Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2016-2027
Figure 93: Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2016-2020
Figure 94: Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2021-2027
Figure 95: Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Market by Country (in %), 2020 & 2027
Figure 96: Saudi Arabia Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2016-2027
Figure 97: Turkey Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2016-2027
Figure 98: Iran Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2016-2027
Figure 99: UAE Diagnostic Radiopharmaceuticals & Contrast Media Market (in US$ Million), 2016-2027
Figure 100: Market Value Chain

List of Tables

Table 1: Global Diagnostic Radiopharmaceuticals & Contrast Media Market Portraiture
Table 2: Global Radiopharmaceuticals Market by Type (in US$ Million), 2020 & 2027
Table 3: Global SPECT Market by Type (in US$ Million), 2020 & 2027
Table 4: Global PET Market by Type (in US$ Million), 2020 & 2027
Table 5: Global Radiopharmaceuticals Market by Application (in US$ Million), 2020 & 2027
Table 6: Global Diagnostics Market by Disease Type (in US$ Million), 2020 & 2027
Table 7: Global Therapeutics Market by Disease Type (in US$ Million), 2020 & 2027
Table 8: Global Contrast Media Market by Type (in US$ Million), 2020 & 2027
Table 9: Global Contrast Media Market by Procedure (in US$ Million), 2020 & 2027
Table 10: Global Contrast Media Market by Application (in US$ Million), 2020 & 2027
Table 11: Global Diagnostic Radiopharmaceuticals & Contrast Media Market by Region (in US$ Million), 2020 & 2027
Table 12: Europe Diagnostic Radiopharmaceuticals & Contrast Media Market by Country (in US$ Million), 2020 & 2027
Table 13: North America Diagnostic Radiopharmaceuticals & Contrast Media Market by Country (in US$ Million), 2020 & 2027
Table 14: Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Market by Country (in US$ Million), 2020 & 2027
Table 15: Latin America Diagnostic Radiopharmaceuticals & Contrast Media Market by Country (in US$ Million), 2020 & 2027
Table 16: Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Market by Country (in US$ Million),
2020 & 2027
Table 17: List of Key Players